CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech
BOSTON, Dec. 17, 2025 /PRNewswire/ -- CranioSense, Inc., a neurotechnology company developing the world's first noninvasive intracranial pressure (ICP) diagnostic and...